There’s no question about the popularity of GLP-1 weight loss drugs like Ozempic and Wegovy, but some doctors are worried the ...

GLP-1: Glucagon-like peptide-1; RA: receptor agonist ... and similarly low incidence of hypoglycemia, as well as decreased incidence of nausea and vomiting. Studies on LA GLP1-RAs have shown ...

Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use in patients with type 2 diabetes is linked to a reduced risk of developing certain hematologic cancers compared to insulin and metformin.

HealthDay News — Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with better graft and patient survival among kidney transplant recipients with diabetes, according to a study ...

(KOLN) - Popular GLP-1 drugs ... and use GLP-1 medications at the same time may be putting themselves at risk of health complications. She said there’s an increased risk of hypoglycemia or ...

Consuming sugars or carbohydrates can treat hypoglycemia. Also, doctors do not recommend GLP-1 agonists to pregnant people ...

Glargine U300 use was common, especially with increased CKD stages and baseline HbA1c levels among patients with type 2 diabetes.

HealthDay News — For patients with type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a reduced risk for developing hematologic cancers compared ...

As earlier outlined, short-term studies in animals and humans have shown GLP-1 to have some direct vasorelaxation ... outcomes in patients receiving GLP1-RA therapy. There are no published studies ...

GLP-1 RA use was linked to lower risks for myelodysplastic syndromes and myeloproliferative neoplasms compared with metformin. HealthDay News — For patients with type 2 diabetes (T2D), glucagon-like ...